Nestlé Health Science delivers 6.6% growth, sales surge due to infant formula shortages
date:Jul 29, 2022
gling to obtain the necessary ingredients they need for their products, with shipping delays and price hikes exacerbating the issues.

Impact of external factors
The company implemented price increases in a responsible manner, according to Schneider. Its organic growth reached 8.1%, with real internal growth of 1.7% and 6.5% pricing.

We limited the impact of unprecedented inflationary pressures and supply chain constraints on our margin development through disciplined cost control and operatio
3/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/21 10:16